(Q58053589)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Elisabet Guinó

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Víctor Moreno

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

C Santos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A López-Doriga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

M Navarro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J Mateo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

S Biondo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

M Martínez Villacampa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

G Soler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

X Sanjuan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

B Laquente

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

E Kreisler

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

R Frago

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J R Germà

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

R Salazar

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

414-422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

Estimates of cancer incidence and mortality in Europe in 2008.

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

The validity of the Royal College of Pathologists' colorectal cancer minimum dataset within a population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Vascular invasion is underrecognized in colorectal cancer using conventional hematoxylin and eosin staining.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Impact of the number of histologically examined lymph nodes on prognosis in colon cancer: a population-based study in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

The impact of spontaneous tumour perforation on outcome following colon cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Adjuvant chemotherapy for stage II colon cancer with poor prognostic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12028

21 January 2018

Identifiers

DOI

10.1111/CODI.12028

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974322%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference